Objectives: To characterize a pan-drug-resistant Serratia marcescens clinical isolate carrying the New Delhi metallo-b-lactamase (NDM)-1.
Introduction
The New Delhi metallo-b-lactamase (NDM) is a carbapenemase that has disseminated globally since 2008.
1 NDM-carrying bacteria exhibit resistance to all b-lactam antibiotics except monobactams. Since bla NDM is often associated with other antibiotic resistance genes, NDM-producing bacteria can per se be considered as MDR organisms. 2, 3 Thus, treatment of infections with NDM-producing bacteria is a major challenge, leaving very few therapeutic options, mostly tigecycline or colistin. 2 Horizontal gene transfer of conjugative NDM-1-harbouring plasmids of broad host range is the molecular basis for the efficient transmission of NDM-1. Transfer of bla NDM-1 into new, more virulent and fitter strains or into species that have pronounced intrinsic antibiotic resistance constitutes a major public health threat. This would finally lead to NDM-1-carrying bacteria that are both extensively drug resistant and highly pathogenic.
In this study, we describe a pan-drug-resistant (PDR) Serratia marcescens clinical isolate harbouring bla NDM-1 on a highly transferable plasmid and analyse its pathogenicity.
Materials and methods

Bacterial isolates
S. marcescens clinical isolates SM1890 and SM1978 were recovered from two patients hospitalized at Frankfurt University Hospital. S. marcescens ATCC 13880 was purchased from DSMZ, Braunschweig, Germany. Sodium azide-resistant S. marcescens TO59 was a clinical isolate from a bloodstream infection (BSI). The genetic relatedness of S. marcescens isolates was investigated by repetitive element palindromic (rep)-PCR and ERIC-PCR as previously reported. Antimicrobial susceptibility testing and detection of b-lactamase production Antimicrobial susceptibility was evaluated by determining the MIC using antibiotic gradient tests (Liofilchem, Roseto degli Abruzzi, Italy and bioMé rieux, Nü rtingen, Germany) following interpretation guidelines set by EUCAST. 6 Double disc synergy tests (DDSTs) using imipenem/EDTA and aztreonam and amoxicillin/clavulanic acid were employed to screen for metallo-b-lactamases and ESBLs, respectively. Detection of acquired carbapenemase, AmpC and ESBL genes was done by PCR analysis including the bla genes for carbapenemases NDM, VIM, IMP, GIM, SME, VEB, PER, GES, OXA-48 and KPC, plasmid-encoded AmpC genes for CMY, DHA, ACC, MOX, LAT, BIL, MIR, ACT and FOX, and ESBL genes for TEM, CTX-M and SHV. 7 -11 Plasmid analysis and horizontal gene transfer of pNDM-1
Plasmid size was estimated by PFGE after S1 nuclease treatment. Plasmid incompatibility groups were determined by PCR-based replicon typing. 12 Horizontal gene transfer of pNDM-1 was evaluated by transconjugation assays using 10 6 cfu of SM1890 as a donor and 10 6 cfu of Escherichia coli J53 or Klebsiella pneumoniae PRZ as recipients. After 24 h incubation, transconjugants were selected using LB plates containing sodium azide (100 mg/L) and amoxicillin/clavulanic acid (200 mg/L).
In vivo infection model
Larvae of the greater wax moth (Galleria mellonella) were obtained from Angel Bä r (Frankfurt) and inoculated with 10 mL of bacterial suspensions by injection into the haemocoel via the last left proleg. Caterpillars were incubated in Petri dishes at 378C for 72 h and scored for survival by two independent observers daily. For determination of LD 50 , a series of 10-fold serial dilutions were injected and LD 50 values were calculated after 24 h by non-linear regression analysis. 13 
Results
Isolation of a PDR S. marcescens isolate
In January 2014, a carbapenem-resistant S. marcescens isolate (termed SM1978) was recovered from rectal swabs during admission screening of a leukaemia patient. The patient was isolated in a single room and treated according to national and local infection control guidelines. This included an extensive terminal disinfection of the sickroom after discharge of the patient. One day later, another patient was transferred to the same room. Within 15 days of hospitalization, the patient developed a urinary tract infection and carbapenem-resistant S. marcescens (termed SM1890) at .10 6 cfu/mL was isolated from urine. ERIC-and rep-PCR of genomic DNA of both isolates revealed a similar banding pattern, suggesting clonality ( Figure S1 , available as Supplementary data at JAC Online). Thus, a nosocomial source was considered as the causative link, even though retrospective analysis and extensive environmental sampling did not reveal the reservoir.
SM1890 and SM1978 were resistant to all antibiotics recommended by EUCAST for the susceptibility testing of Enterobacteriaceae, with both isolates exhibiting identical MIC values ( Phenotypic ESBL and AmpC screening by DDST was positive, and PCR analyses and subsequent sequencing revealed the presence of bla TEM-1 , bla SHV-12 and bla CMY-6 (data not shown). The DDST with imipenem/EDTA was positive, suggesting the production of a metallo-b-lactamase, which was verified by PCR detection of bla NDM-1 .
To investigate genetic localization and transferability of bla NDM-1 , transconjugation assays were performed using SM1890 as the donor. bla NDM-1 was successfully transferred to E. coli J53 and K. pneumoniae PRZ, suggesting its localization on a plasmid. Strikingly, the conjugation frequency was high, yielding 50% of E. coli J53 harbouring NDM-1 after 24 h. The high frequency was recorded irrespectively of whether transconjugant numbers were related to donor or recipient cfu [0.53 (95% CI 0.12 -0.94) and 0.45 (95% CI 0.13 -0.83), respectively].
Transconjugants expressing NDM-1 were non-susceptible to all tested b-lactam antibiotics, including aztreonam, suggesting the presence of other b-lactamases besides NDM-1 on the plasmid (Table 1) . Transconjugants were positive for bla CMY-6 , but negative for bla , confirming the results of phenotypic testing. NDM-carrying transconjugants were furthermore resistant to gentamicin, amikacin and tobramycin, indicating the presence of aminoglycoside resistance genes. Transformation assays using P. aeruginosa ATCC 27853 and PU21 or A. baumannii ATCC 17978 as recipients failed to generate NDM-1-positive transformants, suggesting a plasmid with a host range restricted to Enterobacteriaceae. An NDM-positive plasmid of 140 kb in length belonging to incompatibility group IncA/C was detected in both SM1890 and NDM-1 transconjugants. Sequencing of 11.2 kb of the genetic environment of bla NDM-1 from SM1890 by primer walking showed the presence of an ISKPn14 insertion sequence upstream of bla NDM-1 ( Figure S2 , GenBank accession no. KJ921649). Several resistance genes, e.g. aacA4, rmtC (aminoglycoside resistance) and sul1, were identified. BLAST analysis revealed the highest identity (99.7%) to sequence KF992018, which was derived from an IncA/C plasmid of 138 kb in a K. pneumoniae isolate from Australia.
Virulence of NDM-carrying S. marcescens SM1890
In order to evaluate the virulence of SM1890, the G. mellonella in vivo infection model was employed. 16 ,17 SM1890 caused a time-and dose-dependent killing of larvae (Figure 1 ). Whereas almost no mortality was observed when 10 1 cfu were injected, 62% of G. mellonella larvae died 24 h post-infection with 10 5 cfu. To compare the virulence of SM1890 with that of other S. marcescens strains, the type strains ATCC 13880 (environmental origin) and TO59 (isolate from BSI) were used. Injection of 10 5 cfu ATCC 13880 resulted in the death of 82% of insects 24 h postinfection, making it more virulent than SM1890. In contrast, injection of a single bacterium of S. marcescens TO59 per larva was sufficient to cause more than 50% mortality (LD 50 0.99 cfu), NDM-1 in PDR S. marcescens which is in line with studies from Chadwick et al., who also reported an LD 50 ,1 cfu for highly virulent strains. 18 This shows that the NDM-containing clinical isolate SM1890 was less virulent than ATCC 13880, and that the results of the Galleria infection model with TO59 correlated with the aggressive clinical properties of this BSI isolate.
Conclusions
Here, we describe a PDR clinical isolate of S. marcescens harbouring bla NDM-1 on a highly conjugative plasmid. The presence of NDM-1 in S. marcescens could become a therapeutic problem since this species has an intrinsic resistance to colistin and reduced susceptibility to tigecycline. These two antibiotics usually retain the highest activity in carbapenemase-producing bacteria and are therefore frequently used for the treatment of infections caused by NDM-1-producing organisms. 2, 3 The origin of SM1890 and SM1978 remains elusive since this clone has never been observed before or afterwards at Frankfurt University Hospital. Furthermore, both affected patients were in single-room isolation prior to detection, all environmental sampling was negative and no history of travel to countries with NDM endemicity was recorded. Interestingly, the 140 kb IncA/C plasmid pNDM-1 described herein shares the highest identity with the plasmid pKP-NDM-1, which has been described in a K. pneumoniae isolate from Australia, and the same ancestor can be assumed.
A high intergenus transferability of pNDM-1 from SM1890 to E. coli and K. pneumoniae was demonstrated. The conjugation frequency was 50%, and therefore much higher than previously reported for different NDM plasmids. 19 The high conjugation frequency could also explain the emergence of NDM-1 in S. marcescens, which has only been reported once as an NDM-1 carrier. 20 In our case, PDR SM1890 was less virulent than an environmental and a BSI isolate in the G. mellonella infection model. However, PDR Enterobacteriaceae that are also highly virulent could become a serious public health threat and would finally lead to untreatable infections. Until new treatment options are available that are effective for current PDR organisms, this scenario can only be prevented by further efforts to contain the dissemination of carbapenem-resistant Enterobacteriaceae. 
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